Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation

被引:43
作者
Aragao Gomes, Luis [1 ,2 ]
Uytterhoeven, Valerie [2 ,3 ,4 ]
Lopez-Sanmartin, Diego [1 ,2 ,11 ]
Tome, Sandra O. [1 ,2 ]
Tousseyn, Thomas [5 ]
Vandenberghe, Rik [2 ,6 ,7 ]
Vandenbulcke, Mathieu [2 ,8 ]
von Arnim, Christine A. F. [9 ,10 ]
Verstreken, Patrik [2 ,3 ,4 ]
Thal, Dietmar Rudolf [1 ,2 ,5 ]
机构
[1] Katholieke Univ Leuven, Dept Imaging & Pathol, Lab Neuropathol, Herestr 49, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium
[3] Katholieke Univ Leuven, Ctr Brain & Dis Res, Dept Neurosci, Leuven, Belgium
[4] VIB, Leuven, Belgium
[5] UZ Leuven, Dept Pathol, Leuven, Belgium
[6] Katholieke Univ Leuven, Expt Neurol Grp, Dept Neurosci, Leuven, Belgium
[7] UZ Leuven, Dept Neurol, Leuven, Belgium
[8] Univ Hosp Leuven, Dept Geriatr Psychiat, Leuven, Belgium
[9] Univ Ulm, Dept Neurol, Ulm, Germany
[10] Univ Med Ctr Gottingen, Dept Geriatr, Gottingen, Germany
[11] Novartis Oncol, Solid Tumors, Barcelona, Spain
关键词
Tau-protein; Site-specific phosphorylation; Tau modification; Preclinical Alzheimer's disease; Neuropathology; ALZHEIMERS ASSOCIATION WORKGROUPS; AMYLOID-BETA-PEPTIDE; NEUROFIBRILLARY TANGLES; NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; HYPERPHOSPHORYLATED TAU; DIAGNOSTIC GUIDELINES; HUMAN BRAIN; MUTANT-TAU; DISEASE;
D O I
10.1007/s00401-020-02251-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Alzheimer's disease (AD), tau-protein undergoes a multi-step process involving the transition from a natively unfolded monomer to large, aggregated structures such as neurofibrillary tangles (NFTs). However, it is not yet clear which events initiate the early preclinical phase of AD tauopathy and whether they have impact on the propagation of tau pathology in later disease stages. To address this question, we analyzed the distribution of tau species phosphorylated at T231, S396/S404 and S202/T205, conformationally modified at the MC1 epitope and fibrillary tau detected by the Gallyas method (Gallyas-tau), in the brains of 15 symptomatic and 20 asymptomatic cases with AD pathology as well as of 19 nonAD cases. As initial tau lesions, we identified phosphorylated-T231-tau diffusely distributed within the somatodendritic compartment (IC-tau) and phosphorylated-S396/pS404-tau in axonal lesions of the white matter and in the neuropil (IN-tau). The subcellular localization of pT231-tau in the cell body and pS396/pS404-tau in the presynapse was confirmed in hP301L mutant Drosophila larvae. Phosphorylated-S202/T205-tau, MC1-tau and Gallyas-tau were negative for these lesions. IC- and IN-tau were observed in all analyzed regions of the human brain, including early affected regions in nonAD cases (entorhinal cortex) and late affected regions in symptomatic AD cases (cerebellum), indicating that tau pathology initiation follows similar processes when propagating into previously unaffected regions. Furthermore, a sequence of AD-related maturation of tau-aggregates was observed, initiated by the appearance of IC- and IN-tau, followed by the formation of pretangles exhibiting pT231-tau, pS396/pS404-tau and pS202/pT205-tau, then by MC1-conformational tau, and, finally, by the formation of Gallyas-positive NFTs. Since cases classified as nonAD [Braak NFT stages < I (including a-1b)] already showed IC- and IN-tau, our findings suggest that these lesions are a prerequisite for the development of AD.
引用
收藏
页码:173 / 192
页数:20
相关论文
共 78 条
  • [1] Staging of neurofibrillary pathology in Alzheimer's disease:: A study of the BrainNet Europe consortium
    Alafuzoff, Irina
    Arzberger, Thomas
    Al-Sarraj, Safa
    Bodi, Istvan
    Bogdanovic, Nenad
    Braak, Heiko
    Bugiani, Orso
    Del-Tredici, Kelly
    Ferrer, Isidro
    Gelpi, Ellen
    Giaccone, Giorgio
    Graeber, Manuel B.
    Ince, Paul
    Kamphorst, Wouter
    King, Andrew
    Korkolopoulou, Penelope
    Kovacs, Gabor G.
    Larionov, Sergey
    Meyronet, David
    Monoranu, Camelia
    Parchi, Piero
    Patsouris, Efstratios
    Roggendorf, Wolfgang
    Seilhean, Danielle
    Tagliavini, Fabrizio
    Stadelmann, Christine
    Streichenberger, Nathalie
    Thal, Dietmar R.
    Wharton, Stephen B.
    Kretzschmar, Hans
    [J]. BRAIN PATHOLOGY, 2008, 18 (04) : 484 - 496
  • [2] Interlaboratory comparison of assessments of Alzheimer disease-related lesions:: a study of the BrainNet Europe consortium
    Alafuzoff, Irina
    Pikkarainen, Maria
    Al-Sarraj, Safa
    Arzberger, Thomas
    Bell, Jeanne
    Bodi, Istvan
    Bogdanovic, Nenad
    Budka, Herbert
    Bugiani, Orso
    Ferrer, Isidro
    Gelpi, Ellen
    Giaccone, Giorgio
    Graeber, Manuel B.
    Hauw, Jean-Jacques
    Kamphorst, Wouter
    King, Andrew
    Kopp, Nicolas
    Korkolopoulou, Penelope
    Kovacs, Gdbor G.
    Meyronet, David
    Parchi, Piero
    Patsouris, Efstratios
    Preusser, Matthias
    Ravid, Rivka
    Roggendorf, Wolfgang
    Seilhean, Danielle
    Streichenberger, Nathalie
    Thal, Dietmar R.
    Kretzschmar, Hans
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (08) : 740 - 757
  • [3] Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals
    Arendt, T
    Stieler, J
    Strijkstra, AM
    Hut, RA
    Rüdiger, J
    Van der Zee, EA
    Harkany, T
    Holzer, M
    Härtig, W
    [J]. JOURNAL OF NEUROSCIENCE, 2003, 23 (18) : 6972 - 6981
  • [4] Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
    Augustinack, JC
    Schneider, A
    Mandelkow, EM
    Hyman, BT
    [J]. ACTA NEUROPATHOLOGICA, 2002, 103 (01) : 26 - 35
  • [5] Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
    Ballatore, Carlo
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) : 663 - 672
  • [6] ACCUMULATION OF ABNORMALLY PHOSPHORYLATED-TAU PRECEDES THE FORMATION OF NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE
    BANCHER, C
    BRUNNER, C
    LASSMANN, H
    BUDKA, H
    JELLINGER, K
    WICHE, G
    SEITELBERGER, F
    GRUNDKEIQBAL, I
    IQBAL, K
    WISNIEWSKI, HM
    [J]. BRAIN RESEARCH, 1989, 477 (1-2) : 90 - 99
  • [7] A SEQUENCE OF CYTOSKELETON CHANGES RELATED TO THE FORMATION OF NEUROFIBRILLARY TANGLES AND NEUROPIL THREADS
    BRAAK, E
    BRAAK, H
    MANDELKOW, EM
    [J]. ACTA NEUROPATHOLOGICA, 1994, 87 (06) : 554 - 567
  • [8] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [9] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [10] Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
    Braak, Heiko
    Alafuzoff, Irina
    Arzberger, Thomas
    Kretzschmar, Hans
    Del Tredici, Kelly
    [J]. ACTA NEUROPATHOLOGICA, 2006, 112 (04) : 389 - 404